Inventor · disambiguated record
James Stefano
Also filed as: STEFANO JAMES · STEFANO JAMES E · STEFANO JAMES ERNEST
30 granted patents·4 pending applications·414 citations·filing 1990–2024
97Inventor score
Top patents by PatentIndex Score
34 records- 0198US7341720B2Targeting of glycoprotein therapeuticsGENZYME CORP·Filed 2006·Granted Mar 11, 2008·85 cites·18 claims
- 0296US11130816B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2019·Granted Sep 28, 2021·6 cites·20 claims
- 0396US8124073B2Targeting of glycoprotein therapeuticsSTEFANO JAMES·Filed 2008·Granted Feb 28, 2012·35 cites·32 claims
- 0495US12110338B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2021·Granted Oct 8, 2024·2 cites·29 claims
- 0594US9580511B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2014·Granted Feb 28, 2017·17 cites·47 claims
- 0693US10214589B2Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2017·Granted Feb 26, 2019·9 cites·18 claims
- 0793US8906379B2Targeting of glycoprotein therapeuticsSTEFANO JAMES·Filed 2012·Granted Dec 9, 2014·18 cites·22 claims
- 0892US11279725B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2019·Granted Mar 22, 2022·6 cites·19 claims
- 0992US10308917B2Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereofGENZYME CORP·Filed 2016·Granted Jun 4, 2019·7 cites·13 claims
- 1090US2025066497A1Site-specific antibody-drug conjugation through glycoengineeringGENZYME CORP·Filed 2024·Application pending·0 cites
- 1187US10464962B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2016·Granted Nov 5, 2019·5 cites·6 claims
- 1287US9441029B2VEGF antagonist compositions and uses thereofSTEFANO JAMES·Filed 2011·Granted Sep 13, 2016·7 cites·32 claims
- 1386US10792342B2Targeting of glycoprotein therapeuticsGENZYME CORP·Filed 2018·Granted Oct 6, 2020·1 cites·20 claims
- 1486US8835614B2Oligosaccharide-protein conjugatesAVILA LUIS Z·Filed 2009·Granted Sep 16, 2014·10 cites·15 claims
- 1585US5556751ASelective amplification system using Q-β replicaseAMOCO CORP·Filed 1994·Granted Sep 17, 1996·63 cites·6 claims
- 1684US9493498B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2014·Granted Nov 15, 2016·6 cites·14 claims
- 1781US10844115B2Bone-targeting antibodiesGENZYME CORP·Filed 2018·Granted Nov 24, 2020·2 cites·6 claims
- 1880US9498518B2Targeting of glycoprotein therapeuticsGENZYME CORP·Filed 2014·Granted Nov 22, 2016·2 cites·43 claims
- 1980US5472840ANucleic acid structures with catalytic and autocatalytic replicating features and methods of useAMOCO CORP·Filed 1990·Granted Dec 5, 1995·71 cites·31 claims
- 2080US2025074975A1Bone-Targeting AntibodiesGENZYME CORP·Filed 2024·Application pending·0 cites
- 2179US12252504B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2022·Granted Mar 18, 2025·0 cites·5 claims
- 2276US8440793B2Peptide analogs of alpha-melanocyte stimulating hormonePERRICONE MICHAEL A·Filed 2009·Granted May 14, 2013·4 cites·10 claims
- 2375US10385108B2Peptide analogs of alpha-melanocyte stimulating hormoneGENZYME CORP·Filed 2017·Granted Aug 20, 2019·1 cites·20 claims
- 2475US9115174B2Peptide analogs of alpha-melanocyte stimulating hormoneGENZYME CORP·Filed 2013·Granted Aug 25, 2015·2 cites·19 claims
- 2574US10792367B2Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acidSANOFI SA·Filed 2017·Granted Oct 6, 2020·1 cites·36 claims
- 2670US9738698B2Peptide analogs of alpha-melanocyte stimulating hormoneGENZYME CORP·Filed 2015·Granted Aug 22, 2017·1 cites·14 claims
- 2769US6297010B1Method for detecting and identifying mutationsGENZYME CORP·Filed 1998·Granted Oct 2, 2001·33 cites·21 claims
- 2868US12098194B2Bone-targeting antibodiesGENZYME CORP·Filed 2020·Granted Sep 24, 2024·0 cites·13 claims
- 2968US6568327B1Trading card having postal markings and method for producing sameFLEER SKYBOX INTERNATIONAL LP·Filed 2000·Granted May 27, 2003·9 cites·35 claims
- 3061US2017042979A1Targeting of glycoprotein therapeuticsGENZYME CORP·Filed 2016·Application pending·0 cites
- 3154US2022403041A1Biparatopic cd73 antibodiesGENZYME CORP·Filed 2020·Application pending·0 cites
- 3253US5763171ANucleic acid structures with catalytic and autocatalytic replicating features and methods of useAMOCO CORP·Filed 1995·Granted Jun 9, 1998·11 cites·21 claims
- 3352US11141489B2Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acidSANOFI SA·Filed 2019·Granted Oct 12, 2021·0 cites·20 claims
- 3441US10806797B2Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugateSANOFI SA·Filed 2016·Granted Oct 20, 2020·0 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →